| #1 | | | Istanbul, Turkey | | 33+ years | Lutetium-177 therapy, Actinium-225 therapy | Advanced prostate cancer with PSMA-targeted therapy | Offers specialized PSMA-targeted therapies with JCI accreditation and collaboration with Johns Hopkins Medicine. Doctors have 40+ publications in tumor biology and targeted therapy. | International Organization for Standardization, Joint Commission International |
| #2 | | | Istanbul, Turkey | | 25+ years | Lutetium-177 therapy, targeted drugs | Advanced or metastatic cancers | JCI-accredited oncology department with access to advanced targeted drugs and personalized therapy plans. Follows NCCN and ESMO protocols for precise treatment. | International Organization for Standardization, Joint Commission International |
| #3 | | | Istanbul, Turkey | | 15+ years | Lutetium-177 therapy | Advanced cancer cases requiring precision treatment | Specializes in Lutetium-177 therapy with a dedicated targeted therapy team led by an experienced oncologist. Offers precise diagnostics with 3T MRI and innovative Elekta Versa HD radiotherapy system. | International Organization for Standardization, Joint Commission International |
| #4 | | | Vienna, Austria | | 44+ years | Gastroscopy, PET/CT | — | — | International Organization for Standardization, World's Best Hospitals 2021 by Newsweek |
| #5 | | | Istanbul, Turkey | | 1+ year | Targeted therapy | — | — | — |
| #6 | | | Barcelona, Spain | | 32+ years23,000+ treatments | Lutetium-177 therapy, personalized targeted therapy based on genetic testing | Advanced melanoma with specific mutations | Offers personalized targeted therapy guided by genetic testing (NGS) for precise treatment. Clinic is JCI accredited with oncologists experienced in managing complex cases. | Joint Commission International , European Foundation for Quality Management |
| #7 | | | Istanbul, Turkey | | 20+ years | Lutetium-177 therapy | Metastatic colorectal cancer | JCI-accredited hospital with specialized oncology team. Offers Lutetium-177 therapy for targeted cancer treatment. Doctors recommend personalized treatment plans based on molecular test results. | Joint Commission International , Turkish Medical Association (Türk Tabıplerı Bırliği) |
| #8 | | | Tel Aviv, Israel | | 38+ years34,000+ treatments | Lutetium-177 therapy | Prostate cancer with metastases | Offers Lutetium-177 PSMA therapy, a targeted approach combining diagnostic PSMA PET/CT and therapy. High success rates and JCI accreditation ensure quality care. | World's Best Smart Hospitals 2021 by Newsweek, World's Best Hospitals 2021 by Newsweek |
| #9 | | | Baku, Azerbaijan | | 17+ years | MRI of one area | — | — | — |
| #10 | | | Bangkok, Thailand | | 19+ years | Targeted therapy, MRI of one area | — | — | ISO 9001:2015 Quality management systems |